Cargando…

What is the optimal target for a T2T approach in axial spondyloarthritis?

Detalles Bibliográficos
Autores principales:	Sieper, Joachim, Poddubnyy, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522449/ https://www.ncbi.nlm.nih.gov/pubmed/34144966 http://dx.doi.org/10.1136/annrheumdis-2021-220603

Ejemplares similares

Treatment of Axial Spondyloarthritis: What Does the Future Hold?
por: Poddubnyy, Denis, et al.
Publicado: (2020)

Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care
por: Poddubnyy, Denis, et al.
Publicado: (2018)

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
por: Protopopov, Mikhail, et al.
Publicado: (2017)

Old and new treatment targets in axial spondyloarthritis
por: Rios Rodriguez, Valeria, et al.
Publicado: (2015)

Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data
por: Redeker, Imke, et al.
Publicado: (2018)

The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study
por: Redeker, Imke, et al.
Publicado: (2020)

Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline results
por: Poddubnyy, Denis, et al.
Publicado: (2021)

Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis
por: Poddubnyy, Denis
Publicado: (2020)

Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis
por: Llop, Maria, et al.
Publicado: (2019)

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial
por: Proft, Fabian, et al.
Publicado: (2021)

In vivo pre-activation of monocytes in patients with axial spondyloarthritis
por: Conrad, Kristina, et al.
Publicado: (2015)

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
por: Torgutalp, Murat, et al.
Publicado: (2022)

Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Patient‐Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey
por: Garrido‐Cumbrera, Marco, et al.
Publicado: (2021)

Choose wisely: imaging for diagnosis of axial spondyloarthritis
por: Diekhoff, Torsten, et al.
Publicado: (2022)

The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study
por: Redeker, Imke, et al.
Publicado: (2020)

Axial spondyloarthritis: coming of age
por: Marzo-Ortega, Helena
Publicado: (2020)

Relation of α(2)-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
por: Hoppe, Berthold, et al.
Publicado: (2020)

Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis
por: Hoppe, Berthold, et al.
Publicado: (2021)

Future Challenges and Critical Approach to Metrology in Patients with Axial Spondyloarthritis
por: Garrido-Castro, Juan L., et al.
Publicado: (2021)

Axial spondyloarthritis including ankylosing spondylitis
por: Braun, Jürgen
Publicado: (2018)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

Drug switching in axial spondyloarthritis patients in Germany – a social listening analysis
por: Kahn, Maria, et al.
Publicado: (2023)

Uveitis in spondyloarthritis
por: Rademacher, Judith, et al.
Publicado: (2020)

New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT
por: Diekhoff, Torsten, et al.
Publicado: (2023)

Referral Patterns, Diagnosis, and Disease Management of Patients With Axial Spondyloarthritis: Results of an International Survey
por: van der Heijde, Désirée, et al.
Publicado: (2014)

Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
por: van Lunteren, Miranda, et al.
Publicado: (2019)

Impact of Certolizumab Pegol on Patient‐Reported Outcomes in Patients With Axial Spondyloarthritis
por: Sieper, J., et al.
Publicado: (2015)

Novel Therapeutic Targets in Axial Spondyloarthritis
por: Worth, Claudia, et al.
Publicado: (2018)

Targeting inflammatory pathways in axial spondyloarthritis
por: Furst, Daniel E., et al.
Publicado: (2019)

Treatment strategies in axial spondyloarthritis: what, when and how?
por: Fragoulis, George E, et al.
Publicado: (2020)

Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time
por: Baraliakos, Xenofon, et al.
Publicado: (2017)

Skin manifestations in spondyloarthritis
por: Meier, Katharina, et al.
Publicado: (2020)

Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study
por: Sieper, Joachim, et al.
Publicado: (2019)

Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers
por: Weiß, Anja, et al.
Publicado: (2014)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis
por: Schoels, M M, et al.
Publicado: (2014)

Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus
por: Hammoudeh, Mohammed, et al.
Publicado: (2016)

Defining the target: clinical aims in axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ge1h2cb5d4rm8o5r6sbnkn6ir2